Cargando…
Obesity and nonalcoholic fatty liver disease associated with adenocarcinoma in patients with lung cancer
Lung cancer has become the leading cause of cancer-related deaths around the world. In addition to genetic risk factors and smoking, the metabolic risk factors remain to be elusive. To evaluate the associations between obesity, nonalcoholic fatty liver disease (NAFLD) and pulmonary adenocarcinoma in...
Autores principales: | Zhu, Chan-Yan, Qu, Ji-Chen, Cao, Hai-Xia, Chen, Guang-Yu, Shi, Yi-Hai, Fan, Jian-Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750340/ https://www.ncbi.nlm.nih.gov/pubmed/31517837 http://dx.doi.org/10.1097/MD.0000000000017098 |
Ejemplares similares
-
Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study
por: Peng, Tao-Chun, et al.
Publicado: (2015) -
Identification of therapeutic targets and mechanisms of tumorigenesis in non-small cell lung cancer using multiple-microarray analysis
por: Zhao, Dan, et al.
Publicado: (2020) -
Lung adenocarcinoma with eosinophilic pleural effusion: A case report
por: Zhou, Xiangxiang, et al.
Publicado: (2021) -
Impact of Coexisting Pulmonary Diseases on Survival of Patients With Lung Adenocarcinoma: A STROBE-Compliant Article
por: Jian, Zhi-Hong, et al.
Publicado: (2015) -
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)